February 2024 – ITHEMYC meeting in Les Diablerets

ITHEMYC meeting in Les Diablerets

On January 29-30, 2024, the ITHEMYC consortium held its Annual meeting in Les Diablerets, Switzerland. The aim of this meeting was to update, discuss and advance the project in a face-to-face meeting with all consortium partners.

Read more

June 2023 – ITHEMYC kicks off

Novel Immunotherapies for Tuberculosis and other Mycobacterial Diseases (ITHEMYC)

The Horizon Europe programme has funded the ITHEMYC project to establish a critical path for selection of promising innovative adjunct TB immunotherapies and progress 2 of these immunotherapies to completion of preclinical proof of concept.

Read more